v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 59,959 $ 45,091
Accounts receivable 1,731 1,995
Contract assets and unbilled receivables (Note 10) 984 1,170
Prepaids and other current assets 3,927 1,788
Total current assets 66,601 50,044
Property and equipment, net 186 199
Total assets 66,787 50,243
Current liabilities:    
Accounts payable 4,422 3,293
Accrued expenses 4,918 4,488
Total current liabilities 9,340 7,781
Warrant liabilities 77,349 25,985
Funding agreement, related party 1,198 1,129
Total liabilities 87,887 34,895
Commitments and contingencies (Note 3 and Note 9)
Series B preferred stock, par value $0.0001; 7,374,632 shares and no shares were designated as of March 31, 2026 and December 31, 2025, respectively; 7,374,632 shares and no shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively. 24,736 0
Stockholders’ (deficit) equity:    
Preferred stock, par value $0.0001; 2,625,368 shares and 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; no shares issued and outstanding at March 31, 2026 and December 31, 2025. 0 0
Common stock, par value $0.0001; 125,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 71,402,472 and 69,894,507 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively. 7 7
Additional paid-in capital 208,281 203,930
Accumulated deficit (254,124) (188,589)
Total stockholders’ (deficit) equity (45,836) 15,348
Total liabilities, convertible preferred stock and stockholders’ (deficit) equity $ 66,787 $ 50,243

Source